GAMMAGARD S/D IMMUNE GLOBULIN I.V. 2.5 G

Ülke: İsrail

Dil: İngilizce

Kaynak: Ministry of Health

Aktif bileşen:

IMMUNOGLOBULIN NORMAL HUMAN 50 MG/ML

Mevcut itibaren:

TEVA MEDICAL MARKETING LTD.

ATC kodu:

J06BA02

Farmasötik formu:

POWDER FOR SOLUTION FOR INJECTION

Uygulama yolu:

I.V

Tarafından üretildi:

BAXTER HEALTHCARE CORPORATION, USA

Terapötik grubu:

IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.

Terapötik endikasyonlar:

Replacement therapy in:• primary immunodeficiency syndromes (PID) such as: - congenital agammaglobulinaemia and hypogammaglobulinaemia; - common variable immunodeficiency; - severe combined immunodeficiency; - Wiskott Aldrich syndrome.• myeloma or chronic lymphocytic leukaemia (CLL) with severe secondary hypogammaglobulinaemia and recurrent infections.• children with congenital AIDS and recurrent infections.Immunomodulation• idiopathic thrombocytopenic purpura (ITP), in children or adults at high risk of bleeding or prior to surgery to correct the platelet count.• Guillain Barr? syndrome. In this case GAMMAGARD S/D (Solvent/Detergent) is only indicated in patients showing one of the following symptoms: - progressive paresis (the patient cannot walk more than 10 m on his own); - signs of a respiratory disorder (clinically observed or demonstrated by measuring the vital capacity at the patient’s bed); - signs of oropharyngeal paresis.• Kawasaki disease.Allogeneic bone marrow transplantation

Yetkilendirme tarihi:

2010-07-01